TuHURA Biosciences (HURA) Research & Development (2012 - 2026)

TuHURA Biosciences' (HURA) quarterly Research & Development came in at $5.2 million in Q1 2026, up 14.21% year-on-year from $4.6 million in Q1 2025, and down 13.59% quarter-over-quarter from $6.1 million in Q4 2025.

TuHURA Biosciences (HURA) Research & Development (2012 - 2026) Analysis & Trends

TuHURA Biosciences' Research & Development history runs 15 years deep, the most recent figure standing at $5.2 million for Q1 2026.

  • On a quarterly basis, Research & Development rose 14.21% year-over-year to $5.2 million in Q1 2026; TTM through Mar 2026 was $21.2 million, a 11.52% decrease from a year earlier, with the FY2025 full-year figure at $20.5 million, up 53.97% from the prior year.
  • Research & Development retreated to $5.2 million in Q1 2026 per HURA's latest filing, from $6.1 million in the prior quarter.
  • Across five years, Research & Development topped out at $9.4 million in Q3 2024 and bottomed at -$1.9 million in Q2 2023.
  • The 5-year median for Research & Development is $3.6 million (2024), against an average of $3.9 million.
  • Across the five-year window, Research & Development tumbled 47.23% in 2022 and jumped 445.11% in 2024, its largest moves.
  • Year by year, Research & Development stood at $2.1 million in 2022, then decreased by 4.32% to $2.0 million in 2023, then soared by 375.07% to $9.4 million in 2024, then slumped by 35.3% to $6.1 million in 2025, then fell by 13.59% to $5.2 million in 2026.
  • Per Business Quant, the three latest HURA Research & Development figures stand at $5.2 million (Q1 2026), $6.1 million (Q4 2025), and $5.0 million (Q3 2025).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) R&D (Qtr)
1 Oculis Holding AG 66,621.14 Bn 66,620.85 Bn - -17.94 Mn
2 Nanobiotix 1,915.18 Bn 1,915.11 Bn - -
3 Akari Therapeutics 1,014.18 Bn 1,014.18 Bn - 1.46 Mn
4 BeOne Medicines 471.27 Bn 466.48 Bn 1.35 Bn 541.22 Mn
5 Vertex Pharmaceuticals 121.81 Bn 114.57 Bn 2.59 Bn 961.60 Mn
6 Regeneron Pharmaceuticals 69.58 Bn 60.82 Bn 3.31 Bn 1.54 Bn
7 Belite Bio 62.72 Bn 62.72 Bn - 15.66 Mn
8 Argenx Se 55.51 Bn 50.33 Bn 1.41 Bn 1.37 Bn
9 Revolution Medicines 37.35 Bn 37.35 Bn - 343.97 Mn
10 TuHURA Biosciences 132.62 Mn 132.62 Mn - 5.23 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 5.23 Mn
Dec 31, 2025 6.06 Mn
Sep 30, 2025 4.97 Mn
Jun 30, 2025 4.93 Mn
Mar 31, 2025 4.58 Mn
Sep 30, 2024 9.36 Mn
Jun 30, 2024 6.41 Mn
Mar 31, 2024 3.59 Mn
Dec 31, 2023 1.97 Mn
Sep 30, 2023 1.86 Mn
Jun 30, 2023 -1.86 Mn
Mar 31, 2023 2.01 Mn
Dec 31, 2022 2.06 Mn
Sep 30, 2022 3.17 Mn
Mar 31, 2022 3.47 Mn
Dec 31, 2021 3.90 Mn
Sep 30, 2021 3.79 Mn
Jun 30, 2021 4.03 Mn
Mar 31, 2021 3.84 Mn
Dec 31, 2020 2.58 Mn